Organon & Co | OGN - Cost Of Sales

Stock Price
7.32
Daily Change
0.09 1.24%
Monthly
-17.66%
Yearly
-50.90%
Q1 Forecast
7.85

Organon & Co reported $745M in Cost of Sales for its fiscal quarter ending in September of 2025.





Cost Of Sales Change Date
Bristol-Myers Squibb USD 4.92B 657M Dec/2025
Celltrion KRW 402.86B 14.24B Sep/2025
Cspc Pharmaceutical CNY 2.28B 25.27M Sep/2025
Deva Holding AS TRY 991.13M 182.81M Sep/2023
Divis Laboratories Ltd INR 10.63B 1.23B Dec/2025
Gilead Sciences USD 1.62B 50M Dec/2025
Glaxosmithkline GBP 3.01B 853.01M Sep/2025
Kangmei Pharma CNY 1.11B 84.66M Sep/2025
Knight Therapeutics CAD 47.25M 990K Sep/2024
Laboratorios Farma EUR 186.09M 11.06M Dec/2023
Medical Developments International AUD 2.18M 3.09M Jun/2025
Merck USD 3.32B 531M Dec/2025
Neuren Pharmaceuticals AUD 7.45M 6.56M Jun/2025
Novartis USD 3.54B 216M Sep/2025
Organigram Holdings CAD 77.46M 14.63M Sep/2025
Organon & Co USD 745M 25M Sep/2025
Pharma Mar EUR 2.3M 477K Sep/2025
Qiagen NV USD 217.43M 29.65M Dec/2025
Sartorius EUR 450M 18.1M Sep/2025
Sino Biopharmaceutical CNY 3.08B 589.65M Jun/2025
Tilray USD 164.37M 8.41M Sep/2025